The synthesis and biological evaluation of ten Michael acceptors containing potential proteasome inhibitors are described. Cellular targets of azide containing inhibitors Ib and VIIIb were assessed in HEK293T and RAW264.7 cells by a two step labeling strategy, followed by biotin-pulldown, affinity purification, on-bead tryptic digestion and LC-MS2 identification. This strategy appears to be an attractive alternative to gel-based competition assays.
描述了含有潜在
蛋白酶体
抑制剂的十个迈克尔受体的合成与
生物学评价。通过两步标记策略在HEK293T和RAW264.7细胞中评估了含有
叠氮基
抑制剂Ib和VIIIb的细胞内靶点,随后进行
生物素-牵拉、亲和纯化、在珠上胰
蛋白酶消化和LC-MS2鉴定。该策略似乎是一个有吸引力的乳胶凝胶竞争性测定的替代方案。